Wednesday, October 14, 2026

HomeGeneral NewsMedigrowth Medical Cannabis Paediatric Autism Trial Q&A

Medigrowth Medical Cannabis Paediatric Autism Trial Q&A

- Advertisement -


Victorian-based biotech company Medigrowth has answered some questions about its partnership with Deakin University, alongside researchers from Swinburne, to assess the potential benefits of medical cannabis for young autism patients.

Can you tell us a bit about Medigrowth’s involvement in the…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed